Transition Therapeutics Inc., of Toronto, named Laura Agensky vice president of clinical operations

It also named Mark Senner president and director, Christopher Hopton chief financial officer and John Dougherty to corporate development...Transgenomic Inc., of Omaha, Neb., appointed Antonius P. Schuh and Michael B. McNulty to its board

It also promoted Jeff Devlin to chief operating officer and Peter Collins to senior vice president of business development...Fate Therapeutics Inc., of La Jolla, Calif., added Pratik Multani as vice president of clinical development

Acucela Inc., of Bothell, Wash., named Nancy Boman vice president of clinical development and regulatory affairs...Dafna Cohen and Yaron Diament were appointed external directors

aTyr Pharma, of San Diego, named James Cai senior vice president of clinical development at aTyr Pharma and president of Pangu BioPharma, a fully owned aTyr Pharma subsidiary in Hong Kong...Bioheart Inc., of Sunrise, Fla., named Michael Brown and Judy Brown research consultants

Sinobiomed Inc., of Shanghai, China, made these appointments: Anchie Kuo, president and CEO...Brent Suen, head of strategic development and mergers and acquisitions

AVI BioPharma Inc., of Portland, Ore., appointed Stephen B. Shrewsbury chief medical officer and senior vice president of clinical and regulatory affairs Biota Holdings Ltd., of Melbourne, Australia, appointed James Fox as a nonexecutive director and chairman

Sinobiomed Inc., of Shanghai, China, named Anchie Kuo president and CEO...Brent Suen head of strategic development and mergers and acquisitions

Alnylam Pharmaceuticals Inc., of Cambridge, Mass., promoted Akshay Vaishnaw to senior vice president of clinical research...Anecova SA, of Geneva, named Barry W. Wilson, Patrick Aebischer and Jeffrey B. Jump to its board...Gene Network Sciences Inc., of Cambridge, Mass., named Michael Gilman, founder and CEO of Stromedix Inc., to its board

Ensysce Biosciences Inc., of Houston, appointed Lynn Kirkpatrick president and CEO...Horizon Therapeutics Inc., of Skokie, Ill., named Amy Grahn vice president of clinical operations and Iain Duncan senior vice president of operations

and Steve Neben senior director of project and alliance management...Regado Biosciences Inc., of Basking Ridge, N.J appointed Steven L. Zelenkofske senior vice president of clinical and medical affairs

AAIPharma, of Wilmington, N.C., appointed Andreas Dreps senior vice president of global clinical development services and named Ralf Wolter vice president of clinical operations, Europe

MAP Pharmaceuticals Inc., of Mountain View, Calif., appointed Alan H. Cohen vice president of clinical development and medical affairs, pulmonary...MediGene AG, of Martinsried, Germany, appointed Hans Joachim Bochtler vice president of clinical research and development...and Faith Pomeroy-Ward as executive director of investor relations and corporate communications

Francisco Leon to vice president of clinical development and medical affairs...It formed its scientific advisory board with the appointments of Dennis Brown, Xandra Breakefield and Richard L. Edelson, and also appointed Johan Skog director of genetics research

GenVault Corp., of Carlsbad, Calif., named Myla P. Lai-Goldman and Jack Ballantyne to its scientific advisory board...MAP Pharmaceuticals Inc., of Mountain View, Calif., appointed Donald J. Kellerman senior vice president of clinical development and medical affairs...MediGene AG, of Martinsried, Germany, said Thomas Strüngmann and Mathias Albert Boehringer were elected as new supervisory board members

David Mitchell senior director of regulatory affairs and quality assurance...and Jay Rheingold vice president of chemistry, manufacturing and controls

Exiqon, of Vedbaek, Denmark, appointed Cynthia K. French chief scientific officer and Erik Holmlin chief commercial officer...Ikonysis, of New Haven, Conn., named Louise Mawhinney senior vice president and chief financial officer...PharmAthene Inc., of Annapolis, Md., appointed Jordan P. Karp senior vice president and general counsel

RPS Inc., of Fort Washington, Pa., named David A. Green vice president of clinical operations and Neil H. Shusterman senior vice president, medical, regulatory and drug safety...He will become an unpaid vice president and outside director of the Sigma-Aldrich Foundation

Oragenics Inc., of Alachua, Fla., named Marc Siegel and Kevin Sills to its board...Oxford BioMedica, of Oxford, UK, appointed Alan Kingsman chairman and promoted Mike McDonald to CEO...Phytomedics Inc., of Jamesburg, N.J., named Laurie Smaldone Alsup president and CEO